NASDAQ: SLN

Investor Contacts

Home / Investors / Resources / Investor Contacts

Corporate Headquarters

UK

12 Hammersmith Grove
London, W6 7AP

Germany

Robert-Rossle-Str. 10
D-13125 Berlin
Tel: +49 30 9489 2800

US

221 River Street, 9th Floor
Hoboken, NJ 07030

Investor Contact

Gem Hopkins
Head of IR & Corporate Communications
IR@silence-therapeutics.com